Bridgebio Pharma Inc (BBIO)

EBITDA Margin

-85.72%

TTM · Period ending:

BBIO logo

BBIO EBITDA Margin

Latest reported-85.72%
BBIO TTM EBITDA Margin (-921.05% → -85.72%)
High-resolution chart · PNG

BBIO ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Bridgebio Pharma Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-85.7225%
-105.5945%
-124.6888%
-191.441%
-272.925%
-433.1664%
-196.8567%
-160.8413%
-168.0072%
-208.4123%
-6,078.3403%
-5,684.2703%
-8,759.348%
-436.2548%
-511.8522%
-467.0949%
-490.9077%
-778.2559%
-765.7252%
-916.2786%
-782.7412%
-6,052.9063%
-5,649.4323%
-1,928.0537%
-893.5158%
-766.3659%
-688.0473%
-921.0463%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.